Related references
Note: Only part of the references are listed.Phenformin Inhibits Hedgehog-Dependent Tumor Growth through a Complex I-Independent Redox/Corepressor Module
Laura Di Magno et al.
CELL REPORTS (2020)
GPD1 Enhances the Anticancer Effects of Metformin by Synergistically Increasing Total Cellular Glycerol-3-Phosphate
Jianjiang Xie et al.
CANCER RESEARCH (2020)
Benefits of Metformin in Attenuating the Hallmarks of Aging
Ameya S. Kulkarni et al.
CELL METABOLISM (2020)
Phase I study of IM156, a novel potent biguanide oxidative phosphorylation (OXPHOS) inhibitor, in patients with advanced solid tumors.
Sun Young Rha et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Regulatory myeloid cells paralyze T cells through cell-cell transfer of the metabolite methylglyoxal
Tobias Baumann et al.
NATURE IMMUNOLOGY (2020)
Low-Dose Metformin Reprograms the Tumor Immune Microenvironment in Human Esophageal Cancer: Results of a Phase II Clinical Trial
Shuhong Wang et al.
CLINICAL CANCER RESEARCH (2020)
Mitochondrial Metabolism as a Target for Cancer Therapy
Karthik Vasan et al.
CELL METABOLISM (2020)
AMPK regulation of Raptor and TSC2 mediate metformin effects on transcriptional control of anabolism and inflammation
Jeanine L. Van Nostrand et al.
GENES & DEVELOPMENT (2020)
Glutaminase-1 (GLS1) inhibition limits metastatic progression in osteosarcoma
L. Ren et al.
CANCER & METABOLISM (2020)
GAPDH Expression Predicts the Response to R-CHOP, the Tumor Metabolic Status, and the Response of DLBCL Patients to Metabolic Inhibitors
Johanna Chiche et al.
CELL METABOLISM (2019)
Effective breast cancer combination therapy targeting BACH1 and mitochondrial metabolism
Jiyoung Lee et al.
NATURE (2019)
Resolving genetic heterogeneity in cancer
Samra Turajlic et al.
NATURE REVIEWS GENETICS (2019)
Phenformin, But Not Metformin, Delays Development of T Cell Acute Lymphoblastic Leukemia/Lymphoma via Cell-Autonomous AMPK Activation
Diana Vara-Ciruelos et al.
CELL REPORTS (2019)
Host-Microbe-Drug-Nutrient Screen Identifies Bacterial Effectors of Metformin Therapy
Rosina Pryor et al.
CELL (2019)
Effect of Metformin Plus Tyrosine Kinase Inhibitors Compared With Tyrosine Kinase Inhibitors Alone in Patients With Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma A Phase 2 Randomized Clinical Trial
Oscar Arrieta et al.
JAMA ONCOLOGY (2019)
PlGF signaling and macrophage repolarization contribute to the anti-neoplastic effect of metformin
Qiang Ma et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Impact of Addition of Metformin to Abiraterone in Metastatic Castration-Resistant Prostate Cancer Patients With Disease Progressing While Receiving Abiraterone Treatment (MetAb-Pro): Phase 2 Pilot Study
Michael Mark et al.
CLINICAL GENITOURINARY CANCER (2019)
Metformin inhibits the function of granulocytic myeloid-derived suppressor cells in tumor-bearing mice
Peiqi Xu et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
A phase II randomized clinical trial of the effect of metformin versus placebo on progression-free survival in women with metastatic breast cancer receiving standard chemotherapy
Isabel Pimentel et al.
BREAST (2019)
Metformin induces CD11b+-cell-mediated growth inhibition of an osteosarcoma: implications for metabolic reprogramming of myeloid cells and anti-tumor effects
Takenori Uehara et al.
INTERNATIONAL IMMUNOLOGY (2019)
Effect of PTEN inactivating germline mutations on innate immune cell function and thyroid cancer-induced macrophages in patients with PTEN hamartoma tumor syndrome
Yvette J. E. Sloot et al.
ONCOGENE (2019)
Metabolic Rewiring in Response to Biguanides Is Mediated by mROS/HIF-1a in Malignant Lymphocytes
Hamidullah Khan et al.
CELL REPORTS (2019)
Clinical outcomes in non-small-cell lung cancer patients receiving concurrent metformin and immune checkpoint inhibitors
Muhammad Z. Afzal et al.
LUNG CANCER MANAGEMENT (2019)
Metformin regulates global DNA methylation via mitochondrial one-carbon metabolism
E. Cuyas et al.
ONCOGENE (2018)
Metformin directly targets the H3K27me3 demethylase KDM6A/UTX
Elisabet Cuyas et al.
AGING CELL (2018)
Metformin-Induced Reduction of CD39 and CD73 Blocks Myeloid-Derived Suppressor Cell Activity in Patients with Ovarian Cancer
Lifeng Li et al.
CANCER RESEARCH (2018)
Metformin Inhibits Prostate Cancer Progression by Targeting Tumor-Associated Inflammatory Infiltration
Qiuli Liu et al.
CLINICAL CANCER RESEARCH (2018)
Aspartate is an endogenous metabolic limitation for tumour growth
Lucas B. Sullivan et al.
NATURE CELL BIOLOGY (2018)
A Randomized Phase II Study of Metformin plus Paclitaxel/Carboplatin/Bevacizumab in Patients with Chemotherapy-Naive Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer
Kristen A. Marrone et al.
ONCOLOGIST (2018)
Efficacy of metformin in combination with immune checkpoint inhibitors (anti-PD-1/anti-CTLA-4) in metastatic malignant melanoma
Muhammad Zubair Afzal et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Integrated Pharmacodynamic Analysis Identifies Two Metabolic Adaption Pathways to Metformin in Breast Cancer
Simon R. Lord et al.
CELL METABOLISM (2018)
Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1
Jong-Ho Cha et al.
MOLECULAR CELL (2018)
Metformin as an Anticancer Agent
Ales Vancura et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
Gut microbiota and intestinal FXR mediate the clinical benefits of metformin
Lulu Sun et al.
NATURE MEDICINE (2018)
Dual Inhibition of the Lactate Transporters MCT1 and MCT4 Is Synthetic Lethal with Metformin due to NAD plus Depletion in Cancer Cells
Don Benjamin et al.
CELL REPORTS (2018)
Metformin inhibits stromal aromatase expression and tumor progression in a rodent model of postmenopausal breast cancer
Erin D. Giles et al.
BREAST CANCER RESEARCH (2018)
Efficacy of PD-1 Blockade Is Potentiated by Metformin-Induced Reduction of Tumor Hypoxia
Nicole E. Scharping et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Inhibition of monocarboxyate transporter 1 by AZD3965 as a novel therapeutic approach for diffuse large B-cell lymphoma and Burkitt lymphoma
Richard A. Noble et al.
HAEMATOLOGICA (2017)
Phenformin Enhances the Efficacy of ERK Inhibition in NF1-Mutant Melanoma
Sebastian Trousil et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
Phenformin Inhibits Myeloid-Derived Suppressor Cells and Enhances the Anti-Tumor Activity of PD-1 Blockade in Melanoma
Sun Hye Kim et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells
Elodie M. Kuntz et al.
NATURE MEDICINE (2017)
Metformin monotherapy in melanoma: a pilot, open-label, prospective, and multicentric study indicates no benefit
Henri Montaudie et al.
PIGMENT CELL & MELANOMA RESEARCH (2017)
Inhibition of monocarboxyate transporter 1 by AZD3965 as a novel therapeutic approach for diffuse large B-cell lymphoma and Burkitt lymphoma
Richard A. Noble et al.
HAEMATOLOGICA (2017)
Attenuation of CD4+ CD25+ Regulatory T Cells in the Tumor Microenvironment by Metformin, a Type 2 Diabetes Drug
Yuki Kunisada et al.
EBIOMEDICINE (2017)
MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative Phosphorylation
Kyung-Min Lee et al.
CELL METABOLISM (2017)
The mechanisms of action of metformin
Graham Rena et al.
DIABETOLOGIA (2017)
Phase I dose escalation study of temsirolimus in combination with metformin in patients with advanced/refractory cancers
Muhammad R. Khawaja et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
An Ancient, Unified Mechanism for Metformin Growth Inhibition in C. elegans and Cancer
Lianfeng Wu et al.
CELL (2016)
lncRNA NBR2 modulates cancer cell sensitivity to phenformin through GLUT1
Xiaowen Liu et al.
CELL CYCLE (2016)
Metformin Activates AMPK through the Lysosomal Pathway
Chen-Song Zhang et al.
CELL METABOLISM (2016)
Environment Dictates Dependence on Mitochondrial Complex I for NAD plus and Aspartate Production and Determines Cancer Cell Sensitivity to Metformin
Dan Y. Gui et al.
Cell Metabolism (2016)
Metformin Targets Central Carbon Metabolism and Reveals Mitochondrial Requirements in Human Cancers
Xiaojing Liu et al.
Cell Metabolism (2016)
Activation of AMP-activated Protein Kinase by Metformin Induces Protein Acetylation in Prostate and Ovarian Cancer Cells
Luciano Galdieri et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Metformin: An anti-diabetic drug to fight cancer
Marie Daugan et al.
PHARMACOLOGICAL RESEARCH (2016)
Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer
Amira Elgogary et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
Vinit Kumar et al.
TRENDS IN IMMUNOLOGY (2016)
Repurposing phenformin for the targeting of glioma stem cells and the treatment of glioblastoma
Wei Jiang et al.
ONCOTARGET (2016)
Metformin in Cancer Treatment and Prevention
Daniel R. Morales et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
Evidence for biological effects of metformin in operable breast cancer: biomarker analysis in a pre-operative window of opportunity randomized trial
Sirwan M. Hadad et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Prevention of Tumor Growth Driven by PIK3CA and HPV Oncogenes by Targeting mTOR Signaling with Metformin in Oral Squamous Carcinomas Expressing OCT3
Dmitri Madera et al.
CANCER PREVENTION RESEARCH (2015)
Heightening Energetic Stress Selectively Targets LKB1-Deficient Non-Small Cell Lung Cancers
Milica Momcilovic et al.
CANCER RESEARCH (2015)
An Essential Role of the Mitochondrial Electron Transport Chain in Cell Proliferation Is to Enable Aspartate Synthesis
Kivanc Birsoy et al.
CELL (2015)
Supporting Aspartate Biosynthesis Is an Essential Function of Respiration in Proliferating Cells
Lucas B. Sullivan et al.
CELL (2015)
The Energy Sensor AMPK Regulates T Cell Metabolic Adaptation and Effector Responses In Vivo
Julianna Blagih et al.
IMMUNITY (2015)
Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial
Sil Kordes et al.
LANCET ONCOLOGY (2015)
Immune-mediated antitumor effect by type 2 diabetes drug, metformin
Shingo Eikawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Hyperglycemia-induced metabolic compensation inhibits metformin sensitivity in ovarian cancer
Lacey M. Litchfield et al.
ONCOTARGET (2015)
Metformin prevents cancer metastasis by inhibiting M2-like polarization of tumor associated macrophages
Ling Ding et al.
ONCOTARGET (2015)
Genetic Disruption of Lactate/H+ Symporters (MCTs) and Their Subunit CD147/BASIGIN Sensitizes Glycolytic Tumor Cells to Phenformin
Ibtissam Marchiq et al.
CANCER RESEARCH (2015)
Differential effects of metformin on breast cancer proliferation according to markers of insulin resistance and tumor subtype in a randomized presurgical trial
Andrea DeCensi et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Presurgical Trial of Metformin in Overweight and Obese Patients with Newly Diagnosed Breast Cancer
Kevin Kalinsky et al.
CANCER INVESTIGATION (2014)
Serine Deprivation Enhances Antineoplastic Activity of Biguanides
Simon-Pierre Gravel et al.
CANCER RESEARCH (2014)
Anti-diabetic doses of metformin decrease proliferation markers in tumors of patients with endometrial cancer
Ido Laskov et al.
GYNECOLOGIC ONCOLOGY (2014)
Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
Anila K. Madiraju et al.
NATURE (2014)
Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides
Kivanc Birsoy et al.
NATURE (2014)
Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function
Andrea Viale et al.
NATURE (2014)
Synergistic Anti-Cancer Effect of Phenformin and Oxamate
W. Keith Miskimins et al.
PLOS ONE (2014)
Metformin and phenformin deplete tricarboxylic acid cycle and glycolytic intermediates during cell transformation and NTPs in cancer stem cells
Andreas Janzer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
A pilot 'window of opportunity' neoadjuvant study of metformin in localised prostate cancer
A. M. Joshua et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2014)
Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis
William W. Wheaton et al.
ELIFE (2014)
LKB1 Inactivation Dictates Therapeutic Response of Non-Small Cell Lung Cancer to the Metabolism Drug Phenformin
David B. Shackelford et al.
CANCER CELL (2013)
Overcoming Intrinsic Multidrug Resistance in Melanoma by Blocking the Mitochondrial Respiratory Chain of Slow-Cycling JARID1Bhigh Cells
Alexander Roesch et al.
CANCER CELL (2013)
Metformin Decreases Glucose Oxidation and Increases the Dependency of Prostate Cancer Cells on Reductive Glutamine Metabolism
Sarah-Maria Fendt et al.
CANCER RESEARCH (2013)
Metformin Retards Aging in C. elegans by Altering Microbial Folate and Methionine Metabolism
Filipe Cabreiro et al.
CELL (2013)
Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth
Heather A. Hirsch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Phenformin enhances the therapeutic benefit of BRAFV600E inhibition in melanoma
Ping Yuan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study
Saroj Niraula et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Metformin and Other Biguanides in Oncology: Advancing the Research Agenda
Michael Pollak
CANCER PREVENTION RESEARCH (2010)
A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth
Alexander Roesch et al.
CELL (2010)
Metformin, Independent of AMPK, Inhibits mTORC1 in a Rag GTPase-Dependent Manner
Adem Kalender et al.
CELL METABOLISM (2010)
Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
Heather A. Hirsch et al.
CANCER RESEARCH (2009)
Enhancing CD8 T-cell memory by modulating fatty acid metabolism
Erika L. Pearce et al.
NATURE (2009)
Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice
Xu Huang et al.
BIOCHEMICAL JOURNAL (2008)
Metformin and reduced risk of cancer in diabetic patients
JMM Evans et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Share Paper
